This slide show features various images of papillary, clear cell, chromophobe, and tubulocystic renal cell carcinoma.
Addressing Gaps in Education for Non–Clear Cell RCC
A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.
Exploring New Possibilities in Kidney Cancer Detection and Therapy
Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.
Benmelstobart Combo Improves Outcomes Vs Sunitinib in Advanced RCC
Phase 3 data support benmelstobart/anlotinib as a new potential standard in the frontline treatment of patients with advanced renal cell carcinoma.
Finding Ways to Break the Mold in GU Oncology
Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.
Belzutifan Significantly Improves PFS Vs Everolimus in Clear Cell RCC
Data from LITESPARK-005 establish belzutifan as a treatment option in advanced RCC following prior immune checkpoint and antiangiogenic therapies.
Enfortumab Vedotin Combo Gains European Approval for Urothelial Cancer
The decision follows phase 3 EV-302 trial findings showing improved survival with enfortumab vedotin plus pembrolizumab vs chemotherapy in urothelial cancer.